DNA Methyltransferase Inhibitor Zebularine Induces Human Cholangiocarcinoma Cell Death through Alteration of DNA Methylation Status

DNA Methyltransferases: A Novel Target for Prevention and Therapy

(2014) Dharmalingam Subramaniam et al.   Frontiers in Oncology

Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway

(2013) Benjamin Goeppert et al.   HEPATOLOGY

Concise Drug Review: Azacitidine and Decitabine

(2013) E. J. B. Derissen et al.   ONCOLOGIST

DNA Methyltransferase Inhibitor Zebularine Inhibits Human Hepatic Carcinoma Cells Proliferation and Induces Apoptosis

(2013) Kazuaki Nakamura et al.   PLoS One

Zebularine inhibits tumorigenesis and stemness of colorectal cancer via p53-dependent endoplasmic reticulum stress

(2013) Pei-Ming Yang et al.   Scientific Reports

DNA methylation imprinting marks and DNA methyltransferase expression in human spermatogenic cell stages

(2012) C. Joana Marques et al.   Epigenetics

Zebularine inhibits the growth of HeLa cervical cancer cells via cell cycle arrest and caspase-dependent apoptosis

(2012) Bo Ra You et al.   MOLECULAR BIOLOGY REPORTS

DNA methylation profiling reveals novel biomarkers and important roles for DNA methyltransferases in prostate cancer

(2011) Y. Kobayashi et al.   GENOME RESEARCH

High density DNA methylation array with single CpG site resolution

(2011) Marina Bibikova et al.   GENOMICS

The DNA methyltransferase inhibitors zebularine and decitabine induce mitochondria-mediated apoptosis and DNA damage in p53 mutant leukemic T cells

(2011) María J. Ruiz-Magaña et al.   INTERNATIONAL JOURNAL OF CANCER

Identification of methylation profile of HOX genes in extrahepatic cholangiocarcinoma

(2011) Yi Shu   WORLD JOURNAL OF GASTROENTEROLOGY

Overexpression of DNA Methyltransferases 1, 3a, and 3b Significantly Correlates With Retinoblastoma Tumorigenesis

(2010) Yi Qu et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

DNA methyltransferase DNMT3b protein overexpression as a prognostic factor in patients with diffuse large B-cell lymphomas

(2010) Khaled Amara et al.   CANCER SCIENCE

Cholangiocarcinoma: Update and future perspectives

(2010) Manuela Gatto et al.   DIGESTIVE AND LIVER DISEASE

Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation

(2010) Giovanni L Gravina et al.   Molecular Cancer

An Integrated Genomic and Epigenomic Approach Predicts Therapeutic Response to Zebularine in Human Liver Cancer

(2010) J. B. Andersen et al.   Science Translational Medicine

Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells

(2009) Madhavi Billam et al.   BREAST CANCER RESEARCH AND TREATMENT

Targeting DNA Methylation

(2009) J.-P. J. Issa et al.   CLINICAL CANCER RESEARCH

Development of DNA Methyltransferase Inhibitors for the Treatment of Neoplastic Diseases

(2009) Tamer Fandy   CURRENT MEDICINAL CHEMISTRY

Cholangiocarcinoma

(2008) Stefania Mosconi et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment

(2008) Boris Blechacz et al.   HEPATOLOGY